Artykuły w czasopismach na temat „Vaccination – Immunologie”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Vaccination – Immunologie”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Confer, A. W., R. J. Panciera, M. J. Gentry, and R. W. Fulton. "Immunologie response to Pasteurella haemolytica and resistance against experimental bovine pneumonic pasteurellosis, induced by bacterins in oil adjuvants." American Journal of Veterinary Research 48, no. 2 (1987): 163–68. https://doi.org/10.2460/ajvr.1987.48.02.163.
Pełny tekst źródłaBazin, Hervé. "L’histoire des vaccinations. 2e partie : des vaccins pastoriens aux vaccins modernes." Bulletin de la Société Française d'Histoire de la Médecine et des Sciences Vétérinaires 13, no. 1 (2013): 45–63. https://doi.org/10.3406/bhsv.2013.1146.
Pełny tekst źródłaOlsen, S. C., and C. Johnson. "Immune Responses and Safety after Dart or Booster Vaccination of Bison with Brucella abortus Strain RB51." Clinical and Vaccine Immunology 19, no. 5 (2012): 642–48. http://dx.doi.org/10.1128/cvi.00033-12.
Pełny tekst źródłaRidolfi, Irene, Luca Lo Sardo, Stefania Nicola, et al. "MAURIVAX: A Vaccination Campaign Project in a Hospital Environment for Patients Affected by Autoimmune Diseases and Adult Primary Immunodeficiencies." Vaccines 11, no. 10 (2023): 1579. http://dx.doi.org/10.3390/vaccines11101579.
Pełny tekst źródłaRosenblat, Todd L., Mark G. Frattini, Suzanne M. Chanel, et al. "Phase II Trial of WT1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR)." Blood 120, no. 21 (2012): 3624. http://dx.doi.org/10.1182/blood.v120.21.3624.3624.
Pełny tekst źródłaGates, Dana M., Steven A. Cohen, Kelly Orr, and Aisling R. Caffrey. "Pharmacist-Administered Influenza Vaccination in Children and Corresponding Regulations." Vaccines 10, no. 9 (2022): 1410. http://dx.doi.org/10.3390/vaccines10091410.
Pełny tekst źródłaBuckwalter, Matthew, and Pramod Srivastava. "Form of antigen dictates immunity: Irradiated cell vs. whole cell lysate vaccination (48.16)." Journal of Immunology 178, no. 1_Supplement (2007): S77. http://dx.doi.org/10.4049/jimmunol.178.supp.48.16.
Pełny tekst źródłaHuppke, L., C. Gebhardt, L. Grümme, et al. "AB1326 DIFFERENCES IN ADVERSE EVENTS EXPERIENCED BY INDIVIDUALS WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY INDIVIDUALS AFTER SARS-CoV-2 VACCINATION." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1892.1–1892. http://dx.doi.org/10.1136/annrheumdis-2023-eular.497.
Pełny tekst źródłaWu, Yufei, Huanjie Li, Yangyang Wang, et al. "Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines." Vaccines 10, no. 5 (2022): 647. http://dx.doi.org/10.3390/vaccines10050647.
Pełny tekst źródłaRobinson, Stacie J., Michelle M. Barbieri, Samantha Murphy, et al. "Model recommendations meet management reality: implementation and evaluation of a network-informed vaccination effort for endangered Hawaiian monk seals." Proceedings of the Royal Society B: Biological Sciences 285, no. 1870 (2018): 20171899. http://dx.doi.org/10.1098/rspb.2017.1899.
Pełny tekst źródłaHanson, Lars Å., and Sven Arne Silfverdal. "Vaccination immunology." Scandinavian Journal of Infectious Diseases 40, no. 9 (2008): 696–701. http://dx.doi.org/10.1080/00365540802029573.
Pełny tekst źródłaSchmitt, Michael, Anita Schmitt, Markus T. Rojewski, et al. "RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses." Blood 111, no. 3 (2008): 1357–65. http://dx.doi.org/10.1182/blood-2007-07-099366.
Pełny tekst źródłaPerez, S. A., S. Bisias, N. L. Kallinteris, et al. "Results from the first phase I clinical study of the novel Ii-Key/HER2/neu(776–790) hybrid peptide vaccine in patients with prostate cancer." Journal of Clinical Oncology 27, no. 15_suppl (2009): 3011. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.3011.
Pełny tekst źródłaStoffel, Sandro Tiziano, Matthias Schwenkglenks, and Thomas Mutschler. "General Practitioners’ Awareness and Perception of Current Pneumococcal Vaccination for Adult Patients with Known Risk Factors in Switzerland: Evidence from a Survey." Vaccines 11, no. 6 (2023): 1101. http://dx.doi.org/10.3390/vaccines11061101.
Pełny tekst źródłaMaslak, P. G., T. Dao, S. Gupta, et al. "Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease." Journal of Clinical Oncology 24, no. 18_suppl (2006): 6514. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.6514.
Pełny tekst źródłaJokhdar, Hani, Ray Borrow, Abdulrazaq Sultan, et al. "Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia." Clinical Diagnostic Laboratory Immunology 11, no. 1 (2004): 83–88. http://dx.doi.org/10.1128/cdli.11.1.83-88.2004.
Pełny tekst źródłaKeilholz, Ulrich, Anne Letsch, Antonia Busse, et al. "A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS." Blood 113, no. 26 (2009): 6541–48. http://dx.doi.org/10.1182/blood-2009-02-202598.
Pełny tekst źródłaVeronese, Nicola, Nancy Zambon, Marianna Noale, and Stefania Maggi. "Poverty and Influenza/Pneumococcus Vaccinations in Older People: Data from The Survey of Health, Ageing and Retirement in Europe (SHARE) Study." Vaccines 11, no. 9 (2023): 1422. http://dx.doi.org/10.3390/vaccines11091422.
Pełny tekst źródłaMiller, Mechelle, Michael Tracey, Meagan Simpson, and Cecilia Mikita. "Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination." Allergy and Asthma Proceedings 43, no. 6 (2022): 555–58. http://dx.doi.org/10.2500/aap.2022.43.220058.
Pełny tekst źródłavan der Burg, Sjoerd H. "Immunology: prophylactic vaccination." Papillomavirus Report 15, no. 3 (2004): 168–70. http://dx.doi.org/10.1179/095741904225004927.
Pełny tekst źródłaBeverley, P. C. L. "Immunology of vaccination." British Medical Bulletin 62, no. 1 (2002): 15–28. http://dx.doi.org/10.1093/bmb/62.1.15.
Pełny tekst źródłaScognamiglio, Francesca, Maria Pia Fantini, Chiara Reno, et al. "Vaccinations and Healthy Ageing: How to Rise to the Challenge Following a Life-Course Vaccination Approach." Vaccines 10, no. 3 (2022): 375. http://dx.doi.org/10.3390/vaccines10030375.
Pełny tekst źródłaGrochowska, Magdalena, Aleksandra Ratajczak, Gabriela Zdunek, Aleksander Adamiec, Paweł Waszkiewicz, and Wojciech Feleszko. "A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community." Vaccines 9, no. 5 (2021): 475. http://dx.doi.org/10.3390/vaccines9050475.
Pełny tekst źródłaLimentani, S. A., M. Campone, T. Dorval, et al. "Evaluation of a recombinant HER2 vaccine: Induction of specific antibodies, T-cells and preliminary activity in metastatic breast cancer patients." Journal of Clinical Oncology 24, no. 18_suppl (2006): 631. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.631.
Pełny tekst źródłaMYLONAKIS (Μ.Μ. ΜΥΛΩΝΑΚΗΣ), M. M., A. F. KOUTINAS (Α.Φ. ΚΟΥΤΙΝΑΣ), and K. G. PLEVRAKI (Κ.Γ. ΠΛΕΥΡΑΚΗ). "Current aspects on vaccines and immunization in the dog and cat. Part II. Vaccines and vaccinations in the cat and postvaccinal complications." Journal of the Hellenic Veterinary Medical Society 50, no. 2 (2018): 130. http://dx.doi.org/10.12681/jhvms.15706.
Pełny tekst źródłaHartley, Christopher. "Immunologic Strategies for Herpes Vaccination." JAMA 283, no. 6 (2000): 746. http://dx.doi.org/10.1001/jama.283.6.741.
Pełny tekst źródłaFriedman, H. M. "Immunologic Strategies for Herpes Vaccination." JAMA: The Journal of the American Medical Association 283, no. 6 (2000): 746. http://dx.doi.org/10.1001/jama.283.6.746.
Pełny tekst źródłaEnciu, Bianca Georgiana, Daniela Pițigoi, Alina Zaharia, et al. "COVID-19 Vaccination in Romania and the Benefits of the National Electronic Registry of Vaccinations." Vaccines 11, no. 2 (2023): 370. http://dx.doi.org/10.3390/vaccines11020370.
Pełny tekst źródłaCASTAING, Cécile. "Vaccination et passeport immunologique." Revista de Derecho y Genoma Humano Extra 2022, Extra 2022 (2022): 103–22. http://dx.doi.org/10.14679/2004.
Pełny tekst źródłaHofstetter, Amelia R., Nedzad Music, Ram P. Kamal, and Ian A. York. "Influenza-specific ex vivo immune responses in ferrets commensurate with number of vaccinations despite decreased protection for repeat vaccines." Journal of Immunology 204, no. 1_Supplement (2020): 245.15. http://dx.doi.org/10.4049/jimmunol.204.supp.245.15.
Pełny tekst źródłaBennett, Brady W., Lawrence S. Phillips, and Julie A. Gazmararian. "The Association of Vaccination for Common Adult Infectious Diseases and Uptake of COVID-19 Vaccines among 5,006,851 Veterans, 20 December 2020–31 October 2021." Vaccines 12, no. 2 (2024): 145. http://dx.doi.org/10.3390/vaccines12020145.
Pełny tekst źródłaKudrna, David A., George W. Teresa, Jeanene M. Arnzen, K. Scott Beard, and Deborah Olson. "Immunologic memory responses induced in BALB/c mice by cross-linked outer membrane extracts of four Salmonella serotypes." American Journal of Veterinary Research 48, no. 8 (1987): 1199–205. https://doi.org/10.2460/ajvr.1987.48.08.1199.
Pełny tekst źródłaGrabenstein, John D. "Guillain-Barré Syndrome and Vaccination: Usually Unrelated." Hospital Pharmacy 35, no. 2 (2000): 199–207. http://dx.doi.org/10.1177/001857870003500214.
Pełny tekst źródłaGawryś, Ada, Tomasz Gołębiowski, Dorota Zielińska, et al. "Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients." Vaccines 9, no. 2 (2021): 77. http://dx.doi.org/10.3390/vaccines9020077.
Pełny tekst źródłaRahman, Sharif Md Habibur, Md Rukunuzzaman, Rubaiyat Alam, and Khan Lamia Nahid. "Persistence of anti-HBs and immunologic memory in children immunized with hepatitis B vaccine." Bangabandhu Sheikh Mujib Medical University Journal 16, no. 2 (2023): 101–5. http://dx.doi.org/10.3329/bsmmuj.v16i2.67207.
Pełny tekst źródłaCostantino, Andrea, Marco Michelon, Daniele Noviello, et al. "Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease." Vaccines 11, no. 10 (2023): 1591. http://dx.doi.org/10.3390/vaccines11101591.
Pełny tekst źródłaCassimos, Dimitrios C., Evgnosia Effraimidou, Snezana Medic, Theoharis Konstantinidis, Maria Theodoridou, and Helena C. Maltezou. "Vaccination Programs for Adults in Europe, 2019." Vaccines 8, no. 1 (2020): 34. http://dx.doi.org/10.3390/vaccines8010034.
Pełny tekst źródłaMurdaca, Giuseppe, Giovanni Noberasco, Alberto Battaglini, et al. "Systemic Sclerosis and Vaccinations: A Register-Based Cohort Study about Seasonal Influenza and Streptococcus pneumoniae Vaccination Rate and Uptake from Liguria Regional Center, Northwest Italy." Vaccines 8, no. 2 (2020): 204. http://dx.doi.org/10.3390/vaccines8020204.
Pełny tekst źródłaRosamilia, Francesca, Giovanni Noberasco, Dario Olobardi, et al. "Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review." Vaccines 9, no. 11 (2021): 1330. http://dx.doi.org/10.3390/vaccines9111330.
Pełny tekst źródłaGallagher, Megan C., Sarah Haessler, Elizabeth Pecoy-Whitcomb, and Jonathan Bayuk. "Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose." Allergy and Asthma Proceedings 43, no. 1 (2022): 37–39. http://dx.doi.org/10.2500/aap.2022.43.210100.
Pełny tekst źródłaGauld, Natalie, Samuel Martin, Owen Sinclair, Helen Petousis-Harris, Felicity Dumble, and Cameron C. Grant. "Influences on Pregnant Women’s and Health Care Professionals’ Behaviour Regarding Maternal Vaccinations: A Qualitative Interview Study." Vaccines 10, no. 1 (2022): 76. http://dx.doi.org/10.3390/vaccines10010076.
Pełny tekst źródłaLuiten, Rosalie M., Esther W. M. Kueter, Wolter Mooi, et al. "Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients." Journal of Clinical Oncology 23, no. 35 (2005): 8978–91. http://dx.doi.org/10.1200/jco.2005.01.6816.
Pełny tekst źródłaMalchrzak, Wojciech, Mateusz Babicki, Dagmara Pokorna-Kałwak, and Agnieszka Mastalerz-Migas. "The Influence of Introducing Free Vaccination against Streptococcus pneumoniae on the Uptake of Recommended Vaccination in Poland." Vaccines 11, no. 12 (2023): 1838. http://dx.doi.org/10.3390/vaccines11121838.
Pełny tekst źródłaKluczna, Agnieszka, Rafał Orzeł, Anna Bardowska, and Tomasz Dzierżanowski. "The Degree of Acceptance of Cocoon Strategy of Vaccination against Influenza and COVID-19 in Palliative Home Care Professionals and Caregivers." Vaccines 11, no. 7 (2023): 1235. http://dx.doi.org/10.3390/vaccines11071235.
Pełny tekst źródłaYagi, Asami, Yutaka Ueda, Mamoru Kakuda, et al. "Cervical Cancer Protection in Japan: Where Are We?" Vaccines 9, no. 11 (2021): 1263. http://dx.doi.org/10.3390/vaccines9111263.
Pełny tekst źródłaVeronese, Nicola, Giusy Vassallo, Maria Armata, et al. "Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study." Vaccines 10, no. 4 (2022): 555. http://dx.doi.org/10.3390/vaccines10040555.
Pełny tekst źródłaKohrt, Holbrook E., Antonia Müller, Jeanette Baker, et al. "Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation." Blood 118, no. 19 (2011): 5319–29. http://dx.doi.org/10.1182/blood-2011-05-356238.
Pełny tekst źródłaHaque, Afrin, Chomel Mahbub, Biplob Hossain, et al. "Breakthrough Infection Influenced SARS-CoV-2 IgG Antibody Titer in a Group of Healthcare Providers." Journal of Immunology & Clinical Research 8, no. 1 (2025): 1–5. https://doi.org/10.47739/immunology.1051.
Pełny tekst źródłaBellanti, Joseph A. "Basic Immunologic Principles Underlying Vaccination Procedures." Pediatric Clinics of North America 37, no. 3 (1990): 513–30. http://dx.doi.org/10.1016/s0031-3955(16)36902-4.
Pełny tekst źródłaShah, Javeed A., Cecilia S. Lindestam Arlehamn, David J. Horne, Alessandro Sette, and Thomas R. Hawn. "Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis." Journal of Infectious Diseases 220, no. 7 (2019): 1091–98. http://dx.doi.org/10.1093/infdis/jiz285.
Pełny tekst źródła